Green Tea Compound To Treat Genetic Disorder and Two Types of Tumors
August 19, 2011| |
A researcher team at the Donald Danforth Plant Science Center headed by Thomas Smith discovered that green tea can be used for the development of drugs to treat a deadly genetic disorder and two types of tumors.
The genetic disorder known as hyperinsulinism/hyperammonemia (HHS) is caused by loss of glutamate dehydrogenase (GDH) regulation. In this disorder, patients (usually children) react to protein consumption by excessively secreting insulin, becoming severely hypoglycemic, which can be fatal. Smith and colleagues found green tea compounds that can compensate for HHS by shutting down GDH. They are currently investigating the atomic structure of the green tea compounds with the objective of using the compounds to produce better drugs for the disorder.
Two research teams also validated that blocking GDH with green tea is effective at killing two kinds of tumors, glioblastomas and tunerous sclerosis.
Read the news release at http://www.danforthcenter.org/wordpress/?page_id=395&pid=6491.
| |
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
-
See more articles:
-
News from Around the World
- Roundtable Meet Focuses on Building Climate-Resilient Rainfed Agriculture
- AATF Receives US$ 1 Million Boost for Agricultural Technology in Africa
- Kenya Biosafety Regulation Published
- Carnegie Scientists Discover a New Component of a Plant Steroid-activated Pathway
- Partnership Provides Incentives to Sorghum
- Coexistence is not Only Possible, but Necessary
- Genome Mapping Reveals Developmental and Environmental Impacts
- USDA Scientists Study Pest-Fighting Potential of Plant Pigments
- Vietnam to Grow Genetically Modified Corn
- Seminar and Visit of GM Corn Field Trial in Vinh Phuc Province
- Plant Proteins to Help Solve Global Challenges
- Singapore Scientists Get Support in Rice Research for Food Security
- Communication Strategies for the Acceptance and Adoption of Biotech Crops in the Asian Region
- Experts: Biotech Crops are Compatible with Other Resistance Management Strategies
- Ruscoe: UK Should Take the Lead Again in GM Technology
-
Research Highlights
- Research Reveals New Insight on Responses of Corn Hybrids to Seeding Rates
- Overexpression of TaNHX2 Enhances Salt Tolerance of Transgenic Soybean
- Scientists Conduct Developmental Studies of Bt Maize Effects on African Stem Borer
-
Beyond Crop Biotech
- Atlantic Cod Genome Reveals Gap in Immune System
- Green Tea Compound To Treat Genetic Disorder and Two Types of Tumors
- EFSA's Public Consultation on Draft Guidance for Risk Assessment of GM Animal Products
- Engineered Bacteria Secrete Another Species' Toxin to Kill It
-
Announcements
- Biotech Fruit 2012
- Korea International Agriculture Expo 2011 in Jinju City
- International Symposium on Minor Fruits and Medicinal Plants for Health and Ecological Security
- Agricultural Gene-Flow Workshop in September
- 11th Asian Maize Conference
- BioMalaysia 2010
-
Resources
- South African Biotechnology Annual Report
- Brazil's Agricultural Biotechnology Annual Report
-
Read the latest: - Biotech Updates (September 4, 2024)
- Gene Editing Supplement (August 28, 2024)
- Gene Drive Supplement (February 22, 2023)
-
Subscribe to BU: - Share
- Tweet